SecBot SecBot
Institutional Cluster

CHRS

Coherus Oncology, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed8mo ago
Institutional cluster: 3 buyers, 0 sellers (bullish)
Actionable Insight ▲ Bullish

The absence of institutional selling and the strong passive buying suggest underlying confidence in CHRS at current valuations. Traders should monitor for follow-on retail or active manager participation, which could amplify upward momentum. However, given that all buyers are passive, this may reflect index inclusion or rebalancing rather than fundamental conviction.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$1.65
T+0 close · Feb 28, 2026 · via day close
Latest settled
−0.61%
T+60 · $1.64
Vs SPY
−9.93%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 2 $1.65entry
  2. T+1 · 9mo ago 0.00%α +0.91% · $1.65
  3. T+5 · 8mo ago +16.97%α +18.18% · $1.93
  4. T+20 · 8mo ago −3.03%α +4.91% · $1.60
  5. T+60 · 6mo ago −0.61%α −9.93% · $1.64

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three major passive institutional investors, Morgan Stanley, Wells Fargo, and UBS, significantly increased their positions in Coherus Oncology (CHRS) during Q4 2024, collectively adding $2.9M in new holdings with no institutional selling observed. The cluster is entirely composed of mega-passive funds doubling down or adding to existing positions, suggesting growing institutional ownership amid a stable or improving market perception.

Key Financial Metrics

Direction
accumulating
Buy Value
$4.0M
Net Flow
$2.9M

Institutional Positions

Net institutional flow: $2.9M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
Morgan StanleyDOUBLED+155.3%$2.9M$2.1M
UBSDOUBLED+309.4%$978.0K$798.0K
Wells FargoADD+32.4%$85.0K$37.0K

Key Facts

  • Morgan Stanley doubled its stake, increasing holdings by 1.28M shares ($2.1M in value).
  • UBS increased its position by 309.4%, adding $798K in value.
  • Wells Fargo added $37K in value with a 32.4% share increase.
  • No institutional selling was reported in this quarter.
  • Total net buying: $2.9M across three passive institutions.

Financial Impact

Institutions accumulated $2.9M in net new positions in CHRS during Q4 2024.

float ownershipinstitutional ownershiptrading volume

Risk Factors

  • All buyers are passive managers, reducing the signal strength of active conviction.
  • Market cap remains low ($250M), making the stock vulnerable to volatility despite institutional inflows.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-CHRS-2024-Q4

US Market Status

Market Closed · Opens in 6h 5m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 28, 2026